C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agen

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

540456, 514183, A61K 31395, C07D49116

Patent

active

052739791

ABSTRACT:
Described is a process for producing a new immunosuppressant, a C-31 desmethyl, C-19/C-22 cyclic hemiketal biotransformation analog (Compound I) of FR-900520, under novel fermentation conditions utilizing the novel microorganism, Streptomyces, lavendulae ATCC No. 55209. Also disclosed is the C-31 methylated derivative (Compound II) of Compound I produced by enzymatic methylation using 31-O-desmethylimmunomycin O-methyl transferase, (DIMT), a methyl transferase enzyme. The macrolide immunosuppressants are useful in preventing human host rejection of foreign organ transplants, e.g. bone marrow, liver, lung, kidney and heart transplants.

REFERENCES:
patent: 3244592 (1966-04-01), Arai
J. Antibiotics A15, pp. 231-232, by Arai (1962).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1542832

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.